Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

Mochida claims new formulation for ulinastatin

Jan. 20, 1997

Takeda claims new approach to diabetes Rx

Jan. 20, 1997

FDA approves topical acne treatment

Jan. 17, 1997

New treatment option for HIV-infected children

Jan. 17, 1997

New impotence Rx now available in U.S.

Jan. 16, 1997

Approval sought for Androtest-SL

Jan. 16, 1997

Generic version of Monistat-7 approved by FDA

Jan. 16, 1997

February review for Medco's vasodilator combination

Jan. 16, 1997

First launch for AccuSite

Jan. 16, 1997

Long-acting calcium channel blocker proves effective in post-MI patients

Jan. 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...